A Randomized Controlled Trial Evaluating Sildenafil Citrate in Relieving Ureteral Stent Related Symptoms

• Status: Completed
• Trial end date: 2016-11-01
• Target enrollment: 0
• Participant gender: Male

Summary

Despite its beneficial effect, ureteral stents may produce symptoms (such as hematuria, dysuria, frequency, urgency, urge incontinence and suprapubic or flank pain) that affect the quality of life in 70-80%.

This study will be conducted to evaluate the role of Phosphodiestrase 5 inhibitor (Sildenafil Citrate) in relieving these symptoms.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Phosphodiesterase 5 Inhibitors; Sildenafil Citrate

Criteria

Inclusion Criteria:

1. Patient aged >18 years

Exclusion Criteria:

1. Patients who had LUTS before DJ stent fixation

2. DJ stent fixation after open surgery

3. Contraindication to Sildenafil citrate